OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical Advances and Perspectives in Targeted Radionuclide Therapy
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1733-1733
Open Access | Times Cited: 28
Nicolas Lepareur, Barthélémy Ramée, Marie Mougin‐Degraef, et al.
Pharmaceutics (2023) Vol. 15, Iss. 6, pp. 1733-1733
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Glioblastoma Therapy: Past, Present and Future
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Elena Obrador, Paz Moreno-Murciano, María Oriol‐Caballo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2529-2529
Open Access | Times Cited: 61
Experimental and computational evaluation of alpha particle production from laser-driven proton–boron nuclear reaction in hole-boring scheme
M. Huault, T. Carrière, H. Larreur, et al.
Physics of Plasmas (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1
M. Huault, T. Carrière, H. Larreur, et al.
Physics of Plasmas (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 1
A trial of radiolabeled antibody yttrium‐90–FF‐21101 for the treatment of advanced ovarian and other cancers
Devalingam Mahalingam, Taofeek K. Owonikoko, Ebrahim S. Delpassand, et al.
Cancer (2025) Vol. 131, Iss. 1
Open Access | Times Cited: 1
Devalingam Mahalingam, Taofeek K. Owonikoko, Ebrahim S. Delpassand, et al.
Cancer (2025) Vol. 131, Iss. 1
Open Access | Times Cited: 1
Future Treatment Strategies for Cancer Patients Combining Targeted Alpha Therapy with Pillars of Cancer Treatment: External Beam Radiation Therapy, Checkpoint Inhibition Immunotherapy, Cytostatic Chemotherapy, and Brachytherapy
Ruth Winter, Mariam Amghar, Anja Wacker, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1031-1031
Open Access | Times Cited: 5
Ruth Winter, Mariam Amghar, Anja Wacker, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 8, pp. 1031-1031
Open Access | Times Cited: 5
The Use of Technetium-99m Radioactive Isotope in The Diagnosis and Treatment of Thyroid Diseases: A Review
S. Mohammed
Al-Kitab Journal for Pure Sciences (2025) Vol. 9, Iss. 01, pp. 51-67
Open Access
S. Mohammed
Al-Kitab Journal for Pure Sciences (2025) Vol. 9, Iss. 01, pp. 51-67
Open Access
Targeted Covalent Modification Strategies for Drugging the Undruggable Targets
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access
La médecine nucléaire : spécificités et enjeux particuliers en radioprotection
J.-P. Vuillez
Annales des Mines - Responsabilité et environnement (2025) Vol. n° 117, Iss. 1, pp. 99-103
Closed Access
J.-P. Vuillez
Annales des Mines - Responsabilité et environnement (2025) Vol. n° 117, Iss. 1, pp. 99-103
Closed Access
An overview of current phase 3 radiopharmaceutical therapy clinical trials
Nicolas Lepareur
Frontiers in Medicine (2025) Vol. 12
Open Access
Nicolas Lepareur
Frontiers in Medicine (2025) Vol. 12
Open Access
« Optimizing Imaging and Dose–Reponse in Radiotherapies » XVIe édition de l’atelier organisé par le réseau « Vectorisation, Imagerie, Radiothérapies » du Cancéropôle Grand-Ouest – 4–7 octobre 2023, Erquy, France
Françoise Léost, Vincent Potiron, Nicolas Lepareur, et al.
Bulletin du Cancer (2025)
Closed Access
Françoise Léost, Vincent Potiron, Nicolas Lepareur, et al.
Bulletin du Cancer (2025)
Closed Access
Role of emerging theranostic technologies in precision oncology: revolutionizing cancer diagnosis and treatment
Biruk Demisse Ayalew, Abdullah, Saim Mahmood Khan, et al.
ONCOLOGIE (2025)
Closed Access
Biruk Demisse Ayalew, Abdullah, Saim Mahmood Khan, et al.
ONCOLOGIE (2025)
Closed Access
Exploring the landscape of current in vitro and in vivo models and their relevance for targeted radionuclide theranostics
Lisa Bokhout, Joana D. Campeiro, Simone U. Dalm
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Lisa Bokhout, Joana D. Campeiro, Simone U. Dalm
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Design of a Tetravalent RGD Peptide Capable of Simultaneous Binding with Multiple Integrin αvβ3 for Targeted Radionuclide Therapy
Yuki Mizuno, Thanakrit Suebboonprathueng, Satoru Onoe, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Yuki Mizuno, Thanakrit Suebboonprathueng, Satoru Onoe, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Advances with radiopharmaceutical therapy in cancer
Nicolas Lepareur
Elsevier eBooks (2025)
Closed Access
Nicolas Lepareur
Elsevier eBooks (2025)
Closed Access
Targeted Radionuclide Therapy of CLDN18.2-Positive Gastric Cancer with [131I]I-Zolbetuximab: An In Vitro and In Vivo Study
Yang Wang, Shuhua He, Lin Ma, et al.
Molecular Pharmaceutics (2025)
Closed Access
Yang Wang, Shuhua He, Lin Ma, et al.
Molecular Pharmaceutics (2025)
Closed Access
Lanthanide-Based Core-Shell Nanoconstructs for Cancer Theragnostics
Dipak Bari, Vivek Rajkule, S.D. Tiwari, et al.
(2025), pp. 525-544
Closed Access
Dipak Bari, Vivek Rajkule, S.D. Tiwari, et al.
(2025), pp. 525-544
Closed Access
[225Ac]Ac-PSMA-617 production method: development of an efficient and reproducible radiolabelling process for establish a clinical routine production
Michela Aurilio, Aureliana Esposito, Monica Buonanno, et al.
Research Square (Research Square) (2025)
Closed Access
Michela Aurilio, Aureliana Esposito, Monica Buonanno, et al.
Research Square (Research Square) (2025)
Closed Access
A PLC based semi-automated extraction chromatographic separation system for the isolation of medical grade no-carrier-added lutetium-177 for targeted cancer therapy
Dheeraj Kumar, Aaditya Shah, Varun Nair, et al.
Reaction Chemistry & Engineering (2025)
Closed Access
Dheeraj Kumar, Aaditya Shah, Varun Nair, et al.
Reaction Chemistry & Engineering (2025)
Closed Access
Efficient α and β− radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model
Hannelore Ceuppens, Ana Rita Pombo Antunes, Laurent Navarro, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Closed Access | Times Cited: 3
Hannelore Ceuppens, Ana Rita Pombo Antunes, Laurent Navarro, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024)
Closed Access | Times Cited: 3
Development of polyethylene glycol-modified gold nanoparticles for the delivery of Lutetium-177- radiopharmaceuticals based on antibodies
Maskur, Hendris Wongso, Titis Sekar Humani, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106104-106104
Closed Access | Times Cited: 2
Maskur, Hendris Wongso, Titis Sekar Humani, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 100, pp. 106104-106104
Closed Access | Times Cited: 2
Preclinical Evaluation of226Ac as a Theranostic Agent: Imaging, Dosimetry, and Therapy
Helena Koniar, Luke Wharton, Aidan Ingham, et al.
Journal of Nuclear Medicine (2024), pp. jnumed.124.267999-jnumed.124.267999
Closed Access | Times Cited: 2
Helena Koniar, Luke Wharton, Aidan Ingham, et al.
Journal of Nuclear Medicine (2024), pp. jnumed.124.267999-jnumed.124.267999
Closed Access | Times Cited: 2
Radionuclide-labelled nanoparticles for cancer combination therapy: a review
Na Sun, Tao Wang, Song Zhang
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Na Sun, Tao Wang, Song Zhang
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
APPLICATION OF ARTIFICIAL INTELLIGENCE IN THE DIAGNOSIS OF THYROID CANCER WITH ENHANCED COMPUTED TOMOGRAPHY
Na Han, Jinrui Fan, Dongwei Chen, et al.
Journal of Mechanics in Medicine and Biology (2024) Vol. 24, Iss. 02
Open Access | Times Cited: 1
Na Han, Jinrui Fan, Dongwei Chen, et al.
Journal of Mechanics in Medicine and Biology (2024) Vol. 24, Iss. 02
Open Access | Times Cited: 1
Navigating the landscape of theranostics in nuclear medicine: current practice and future prospects
Aayushi C. Shah, Akshada S. Dabhade, Hetvi Bharadia, et al.
Zeitschrift für Naturforschung C (2024) Vol. 79, Iss. 9-10, pp. 235-266
Closed Access | Times Cited: 1
Aayushi C. Shah, Akshada S. Dabhade, Hetvi Bharadia, et al.
Zeitschrift für Naturforschung C (2024) Vol. 79, Iss. 9-10, pp. 235-266
Closed Access | Times Cited: 1
Rapid and stable complexation of the α-generators bismuth-212 and lead-212 with a tetraazamacrocyclic chelator bearing thiosemicarbazone pendant arms
Melyssa L. Grieve, Patrick R. W. J. Davey, Paul V. Bernhardt, et al.
Inorganic Chemistry Frontiers (2024)
Closed Access | Times Cited: 1
Melyssa L. Grieve, Patrick R. W. J. Davey, Paul V. Bernhardt, et al.
Inorganic Chemistry Frontiers (2024)
Closed Access | Times Cited: 1
Targeted Nuclear Medicine. Achievements, Challenges and Prospects
M. V. Kovalchuk, Sergey M. Deyev, К. А. Сергунова
Nanobiotechnology Reports (2023) Vol. 18, Iss. 4, pp. 524-541
Open Access | Times Cited: 2
M. V. Kovalchuk, Sergey M. Deyev, К. А. Сергунова
Nanobiotechnology Reports (2023) Vol. 18, Iss. 4, pp. 524-541
Open Access | Times Cited: 2
